Literature DB >> 9663143

Nihilism and pragmatism in tuberculosis control.

P Farmer, E Nardell.   

Abstract

Entities:  

Mesh:

Year:  1998        PMID: 9663143      PMCID: PMC1508280          DOI: 10.2105/ajph.88.7.1014

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  6 in total

1.  Directly observed therapy and treatment completion for tuberculosis in the United States: is universal supervised therapy necessary?

Authors:  R Bayer; C Stayton; M Desvarieux; C Healton; S Landesman; W Y Tsai
Journal:  Am J Public Health       Date:  1998-07       Impact factor: 9.308

2.  Social scientists and the new tuberculosis.

Authors:  P Farmer
Journal:  Soc Sci Med       Date:  1997-02       Impact factor: 4.634

3.  Beyond four drugs. Public health policy and the treatment of the individual patient with tuberculosis.

Authors:  E A Nardell
Journal:  Am Rev Respir Dis       Date:  1993-07

4.  The present position of the tuberculosis problem.

Authors:  A Newsholme
Journal:  Proc Inst Med Chic       Date:  1982 Jul-Sep

5.  Tuberculosis in New York City--turning the tide.

Authors:  T R Frieden; P I Fujiwara; R M Washko; M A Hamburg
Journal:  N Engl J Med       Date:  1995-07-27       Impact factor: 91.245

6.  Public health nihilism vs pragmatism: history, politics, and the control of tuberculosis.

Authors:  A L Fairchild; G M Oppenheimer
Journal:  Am J Public Health       Date:  1998-07       Impact factor: 9.308

  6 in total
  3 in total

1.  Directly observed therapy and tuberculosis treatment completion. Jereb et al. re: Bayer et al.

Authors:  J A Jereb; P M Simone; I M Onorato
Journal:  Am J Public Health       Date:  1999-04       Impact factor: 9.308

2.  Tuberculosis--the tide can be turned, the battle can be won.

Authors:  Alimuddin Zumla
Journal:  J R Soc Med       Date:  2008-03       Impact factor: 5.344

3.  Pseudoscience in medicine: cautionary recommendations.

Authors:  Chris Callaghan
Journal:  Afr Health Sci       Date:  2019-12       Impact factor: 0.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.